Skip to main content
Premium Trial:

Request an Annual Quote

Lonza Group Closes Acquisition of Cell Research Company Amaxa

NEW YORK (GenomeWeb News) – Swiss biopharmaceutical research supply company Lonza Group has closed its acquisition of Amaxa, a provider of cell research and transfection technologies, for an undisclosed sum.
 
Lonza sells products for cell-based research, cell therapy manufacturing, and other ingredients for the chemical and biotech markets. The firm, which first agreed to the deal in late May, said it plans to begin integrating Amaxa, including its 160 employees, into its operations immediately.
 
Amaxa offers technologies for use in gene transfer, gene silencing, and gene-based medicine, and a method for transferring DNA or siRNA directly into the nucleus of primary cells and cell lines.
 
Lonza said in May that the purchase will enhance profit margins and growth for the Lonza Bioscience division.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.